0001140361-21-014360.txt : 20210426 0001140361-21-014360.hdr.sgml : 20210426 20210426185642 ACCESSION NUMBER: 0001140361-21-014360 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210426 FILED AS OF DATE: 20210426 DATE AS OF CHANGE: 20210426 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ocko Matthew CENTRAL INDEX KEY: 0001836089 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40354 FILM NUMBER: 21855426 MAIL ADDRESS: STREET 1: 270 UNIVERSITY AVENUE CITY: PALO ALTO STATE: CA ZIP: 94301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zymergen Inc. CENTRAL INDEX KEY: 0001645842 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 462942439 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6121 HOLLIS STREET, SUITE 700 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (415) 801-8073 MAIL ADDRESS: STREET 1: 6121 HOLLIS STREET, SUITE 700 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: Zymergen, Inc. DATE OF NAME CHANGE: 20150622 4 1 form4.xml FORM 4 X0306 4 2021-04-26 0001645842 Zymergen Inc. ZY 0001836089 Ocko Matthew 270 UNIVERSITY AVENUE PALO ALTO CA 94301 true Common Stock 2021-04-26 4 C 0 210450 A 210450 I See footnote Common Stock 2021-04-26 4 C 0 2936283 A 2936283 I See footnote Common Stock 2021-04-26 4 C 0 2014506 A 2224956 I See footnote Common Stock 2021-04-26 4 C 0 1687050 A 4623333 I See footnote Common Stock 2021-04-26 4 C 0 294401 A 4917734 I See footnote Common Stock 2021-04-26 4 C 0 223945 A 2448901 I See footnote Series A Preferred Stock 2021-04-26 4 C 0 210450 0 D Common Stock 210450 0 I See footnote Series A Preferred Stock 2021-04-26 4 C 0 2936283 0 D Common Stock 2936283 0 I See footnote Series A-1 Preferred Stock 2021-04-26 4 C 0 2014506 0 D Common Stock 2014506 0 I See footnote Series B Preferred Stock 2021-04-26 4 C 0 1684397 0 D Common Stock 1687050 0 I See footnote Series C Preferred Stock 2021-04-26 4 C 0 294401 0 D Common Stock 294401 0 I See footnote Series D Preferred Stock 2021-04-26 4 C 0 223945 0 D Common Stock 223945 0 I See footnote Each share of Series A, Series A-1, Series C and Series D Preferred Stock converted automatically into one share of the Issuer's common stock for no additional consideration upon the completion of the Issuer's initial public offering and has no expiration date. Each share of Series B Preferred Stock converted automatically into 1.0015 shares of the Issuer's common stock for no additional consideration upon the completion of the Issuer's initial public offering and has no expiration date. Represents shares held of record by Data Collective II, L.P. ("DCVC II"). Data Collective II GP, LLC ("DCVC II GP") is the general partner of DCVC II and has sole voting and dispositive power with regard to the shares held by DCVC II. The Reporting Person is a managing member of DCVC II GP and shares voting and dispositive power with respect to the shares held by DCVC II. The Reporting Person disclaims the existence of a "group" and disclaims beneficial ownership of such shares and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares, except to the extent of his indirect pecuniary interest therein, if any. Represents shares held of record by DCVC Opportunity Fund, L.P. ("DCVC Opportunity Fund"). DCVC Opportunity Fund GP, LLC ("DCVC Opportunity Fund GP") is the general partner of DCVC Opportunity Fund and has sole voting and dispositive power with regard to the shares held by DCVC Opportunity Fund. The Reporting Person is a managing member of DCVC Opportunity Fund GP and shares voting and dispositive power with respect to the shares held by DCVC Opportunity Fund. The Reporting Person disclaims the existence of a "group" and disclaims beneficial ownership of such shares and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares, except to the extent of his indirect pecuniary interest therein, if any. /s/ Mina Kim, attorney-in-fact for Matthew Ocko 2021-04-26